Published in Ann Surg on August 01, 1928
THE MEASUREMENT OF SYMPATHETIC VASOCONSTRICTOR ACTIVITY IN THE LOWER EXTREMITIES. J Clin Invest (1930) 32.02
CIRCULATORY DISTURBANCES OF THE EXTREMITIES: WITH SPECIAL REFERENCE TO THROMBO-ANGIITIS OBLITERANS AND ELEPHANTOID CONDITIONS. Cal West Med (1929) 0.75
RELIEF OF PAIN BY PERIPHERAL NERVE BLOCK IN ARTERIAL DISEASES OF THE LOWER EXTREMITIES. Ann Surg (1936) 0.75
THE EFFECT OF ROENTGEN RAYS ON THE RATE OF GROWTH OF SPONTANEOUS TUMORS IN MICE. J Exp Med (1915) 13.91
Biochemical detection of left-ventricular systolic dysfunction. Lancet (1998) 7.51
EXPERIMENTAL STUDIES ON THE GRADUAL OCCLUSION OF LARGE ARTERIES. Ann Surg (1940) 7.02
THE LYMPHOCYTE IN NATURAL AND INDUCED RESISTANCE TO TRANSPLANTED CANCER : II. STUDIES IN LYMPHOID ACTIVITY. J Exp Med (1915) 5.45
THE PRODUCTION OF LYMPHOMATOSIS IN MICE OF KNOWN GENETIC CONSTITUTION. Science (1938) 4.28
Diverticulitis of the Colon. Ann Surg (1946) 3.86
The Treatment of Ileus: As Indicated by Clinical Experience and Experimental Studies. Ann Surg (1932) 3.37
SYMPATHETIC INHIBITION OF THE LARGE INTESTINE IN HIRSCHSPRUNG'S DISEASE. J Clin Invest (1930) 3.29
Reduced thirst after water deprivation in healthy elderly men. N Engl J Med (1984) 3.13
A NEW EXPLANATION OF THE IMPROVED RESULTS FOLLOWING LIGATION OF BOTH ARTERY AND VEIN. Ann Surg (1927) 2.86
Captopril in heart failure. A double blind controlled trial. Br Heart J (1984) 2.85
INTERINNOMINO-ABDOMINAL (HINDQUARTER) AMPUTATION. Ann Surg (1942) 2.81
Embolectomy for Arterial Embolism of the Extremities. Ann Surg (1933) 2.74
Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Br Heart J (1985) 2.74
Evaluation of vulneray activity by an open wound procedure in rats. Arch Int Pharmacodyn Ther (1972) 2.70
An Experimental Study of Antiperistaltic Jejunal Loops. Ann Surg (1949) 2.49
Results from using Vitallium Tubes in Biliary Surgery. Ann Surg (1946) 2.33
Severe hypotension after first dose of enalapril in heart failure. Br Med J (Clin Res Ed) (1985) 2.14
An Evaluation of Pulmonary Embolism following Intravascular Venous Thrombosis. Ann Surg (1947) 2.11
Skin tumors following a single application of methylcholanthrene in C57 brown mice. Am J Pathol (1939) 2.04
STUDIES ON THE ACTIVITY OF THE LUMBAR SYMPATHETIC NERVOUS SYSTEM. Ann Surg (1930) 1.83
NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension. Eur Respir J (2006) 1.81
Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart (2001) 1.77
Elevated troponin levels are associated with sympathoadrenal activation in acute ischaemic stroke. Cerebrovasc Dis (2006) 1.77
Circulating dopamine: its effect on the plasma concentrations of catecholamines, renin, angiotensin, aldosterone and vasopressin in the conscious dog. Clin Sci (Lond) (1981) 1.76
VITALLIUM TUBES IN BILIARY SURGERY. Ann Surg (1942) 1.76
Captopril in renovascular hypertension: long-term use in predicting surgical outcome. Br Med J (Clin Res Ed) (1982) 1.76
Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients. Clin Pharmacol Ther (1980) 1.64
Chondrosarcoma. Ann Surg (1947) 1.60
Angiotensin II, aldosterone and arterial pressure: a quantitative approach. Arthur C. Corcoran Memorial Lecture. Hypertension (1980) 1.60
A microassay for active and total renin concentration in human plasma based on antibody trapping. Clin Chim Acta (1980) 1.58
OBSTRUCTIONS ABOUT THE MESENTERY IN INFANTS. Ann Surg (1936) 1.54
MEDIASTINITIS FOLLOWING CERVICAL SUPPURATION. Ann Surg (1938) 1.51
Endothelin B receptors are functionally important in mediating vasoconstriction in the systemic circulation in patients with left ventricular systolic dysfunction. J Am Coll Cardiol (1999) 1.47
Plasma endothelin in chronic heart failure. Circulation (1992) 1.47
Maintenance of blood pressure by the renin-angiotensin system in normal man. Nature (1981) 1.42
Value of BNP to estimate cardiac risk in patients on cardioactive treatment in primary care. Eur J Heart Fail (2007) 1.38
Hyponatraemic hypertensive syndrome with renal-artery occlusion corrected by captopril. Lancet (1979) 1.37
A radioimmunoassay for plasma arginine-vasopressin in man and dog: application to physiological and pathological states. J Endocrinol (1975) 1.37
The Similarity in Effect of Experimental High Intestinal Obstruction and High Complete Intestinal Fistula. Ann Surg (1931) 1.29
Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol. Br J Clin Pharmacol (1976) 1.22
Recurrent Perforation of Peptic Ulcers. Ann Surg (1932) 1.21
Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure. Br J Clin Pharmacol (1982) 1.19
Measurement of plasma angiotensin II. Clin Sci (Lond) (1985) 1.19
Plasma renin, renin substrate, angiotensin II, and aldosterone in hypertensive disease of pregnancy. Lancet (1973) 1.18
THE DIAGNOSIS AND TREATMENT OF ACUTE PANCREATITIS. Ann Surg (1940) 1.17
Neuroendocrine activation after acute myocardial infarction. Br Heart J (1988) 1.16
Sensitization of the adrenal cortex to angiotensin II in sodium-deplete man. Circ Res (1974) 1.15
The relation of arterial pressure and plasma angiotensin II concentration. A change produced by prolonged infusion of angiotensin II in the conscious dog. Circ Res (1979) 1.15
The Experimental Study of Flash Burns. Ann Surg (1949) 1.12
Enalapril (MK421) and its lysine analogue (MK521): a comparison of acute and chronic effects on blood pressure, renin-angiotensin system and sodium excretion in normal man. Br J Clin Pharmacol (1984) 1.10
Enalapril (MK421) in the treatment of hypertension with renal artery stenosis. J Hypertens Suppl (1983) 1.09
PULSATING, BENIGN GIANT CELL TUMORS OF BONE. Ann Surg (1939) 1.08
How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure? Heart (1999) 1.08
STUDIES ON X-RAY EFFECTS : IV. DIRECT ACTION OF X-RAYS ON TRANSPLANTABLE CANCERS OF MICE. J Exp Med (1919) 1.06
PHLEGMONOUS GASTRITIS: OF BACILLUS AEROGENES CAPSULATUS (B. WELCHII) ORIGIN. Ann Surg (1928) 1.05
Angiotensin- and norepinephrine-induced myocardial lesions: experimental and clinical studies in rabbits and man. Am Heart J (1975) 1.05
Captopril, angiotensin II, and sodium in blood-pressure regulation. Lancet (1979) 1.04
Comparison of fast and slow pressor effects of angiotensin II in the conscious rat. Am J Physiol (1981) 1.03
THE QUANTITATIVE DETERMINATION OF VASOCONSTRICTOR SPASM AS A BASIS FOR THERAPY IN PERIPHERAL ARTERIAL DISEASES. Ann Surg (1932) 1.02
Abnormal relation between exchangeable sodium and the renin-angiotensin system in malignant hypertension and in hypertension with chronic renal failure. Lancet (1973) 1.01
The Lymphocyte as a Factor in Natural and Induced Resistance to Transplanted Cancer. Proc Natl Acad Sci U S A (1915) 1.01
Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension (1995) 1.01
Early treatment with captopril after acute myocardial infarction. Br Heart J (1993) 1.00
Evidence that the acute hypotensive effect of captopril in dogs is not wholly explained by a reduction of plasma angiotensin II and its direct vasoconstrictor effect. Clin Sci (Lond) (1980) 1.00
Recurrent hyperkalaemia due to selective aldosterone deficiency: correction by angiotensin infusion. Br Med J (1973) 0.99
Changes of blood pressure, renin, and angiotensin after bilateral nephrectomy in patients with chronic renal failure. Br Med J (1972) 0.99
Relationship between plasma renin, renin-substrate, angiotensin II, aldosterone and electrolytes in normal pregnancy. J Clin Endocrinol Metab (1975) 0.99
Captopril in a hyponatraemic hypertensive: need for caution in initiating therapy. Lancet (1979) 0.98
Angiotensin II-induced thirst and vasopressin release in man. Clin Sci (Lond) (1985) 0.98
Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects. Br Med J (Clin Res Ed) (1981) 0.98
Enalapril in the treatment of hypertension with renal artery stenosis. Br Med J (Clin Res Ed) (1983) 0.97
SOME ANGIOSPASTIC SYNDROMES IN THE EXTREMITIES. Ann Surg (1931) 0.97
Angiotensin II and its heptapeptide (2-8), hexapeptide (3-8), and pentapeptide (4-8) metabolites in arterial and venous blood of man. Circ Res (1976) 0.97
N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure. Heart (2003) 0.96
Blood pressure in acute and chronic vasopressin excess: studies of malignant hypertension and the syndrome of inappropriate antidiuretic hormone secretion. N Engl J Med (1981) 0.96
ACE (I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (enalaprilat) in humans. Circulation (1998) 0.96
Angiotensin II and angiotensin III in rat blood. Circ Res (1976) 0.96
Furosemide-induced natriuresis is augmented by ultra-low-dose captopril but not by standard doses of captopril in chronic heart failure. Circulation (1992) 0.95
Effects of angiotensin II on arginine-vasopressin in physiological and pathological situations in man. J Endocrinol (1977) 0.94
Sodium and the renin-angiotensin system in essential hypertension and mineralocorticoid excess. Lancet (1974) 0.94
Comparative evaluation of materials used for internal ureteral stents. J Endourol (1993) 0.94
Plasma angiotensin II, predisposition to hypertension, and left ventricular size in healthy young adults. Circulation (1996) 0.94
Cd36 and molecular mechanisms of insulin resistance in the stroke-prone spontaneously hypertensive rat. Diabetes (2000) 0.94
Enalapril in hypertension with renal artery stenosis: long-term follow-up and effects on renal function. J Hypertens Suppl (1984) 0.93
Structural studies on the lipopolysaccharide of a rough strain of Escherichia coli. Eur J Biochem (1972) 0.93
Plasma endothelinlike immunoreactivity levels in IDDM patients with microalbuminuria. Diabetes Care (1992) 0.92
The effect of captopril on blood pressure and angiotensins I, II and III in sodium-depleted dogs: problems associated with the measurement of angiotensin II after inhibition of converting enzyme. Clin Sci (Lond) (1980) 0.92
Amiloride in the treatment of primary hyperaldosteronism and essential hypertension. Clin Endocrinol (Oxf) (1977) 0.92
Hypertension in chronic renal failure. An abnormal relation between sodium and the renin-angiotensin system. Am J Med (1973) 0.91
Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosis. Br Med J (Clin Res Ed) (1982) 0.91
Hypertension and secondary hyperaldosteronism associated with a renin-secreting renal juxtaglomerular-cell tumour. Lancet (1973) 0.91
Investigation of estrogen status and increased stroke sensitivity on cerebral blood flow after a focal ischemic insult. J Cereb Blood Flow Metab (2000) 0.90
Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice. Heart (1997) 0.89
Mechanism of renal hypertension. Lancet (1976) 0.89
Osmotic thirst and vasopressin release in humans: a double-blind crossover study. Am J Physiol (1985) 0.89